Ariel Small/Mid Cap Value Q2 2026 Portfolio Activity
Prestige Consumer Healthcare Inc PBH
$50.22
▲ +0.54%
(+$0.27)
Index member:
S&P/TSX Composite
📅 Earnings This Week
Open
$49.46
Prev Close
$49.95
Day Range
$49.03 – $50.46
52W Range
$42.62 – $75.63
Market Cap
$2.35B
P/E (TTM)
12.52
Beta
0.33
EPS (TTM)
$3.91
📋 Company Profile
| Industry | Pharmaceuticals |
| Sector | Consumer Staples |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2005-02-10 |
| Shares Out. | 47,370,000 |
| Website | prestigebrands.com/ ↗ |
| Phone | 19145246800 |
| Employees | 890 |
| Revenue | $281.6M |
| Gross Profit | $146.3M |
| Net Income | $53.9M |
| Free Cash Flow | $246.4M |
| Total Assets | $3.49B |
| Total Liabilities | $1.61B |
| Equity | $1.89B |
About Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Prestige Consumer Healthcare Inc is a publicly traded company under the ticker symbol PBH on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)